In this issue of Hematology/Oncology Clinics, guest editors Drs. Alexandra P. Wolanskyj-Spinner and Ronald S. Go bring their considerable expertise to the topic of New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia. Top experts in the field cover key topics such as warm AIHA; cold AIHA; drug-induced AIHA; adult Evans syndrome; immunotherapy-associated AIHA; complications of AIHA; and more. Contains 11 relevant, practice-oriented topics including diagnosis and differential diagnosis; red cell antigens and antibodies; traditional and novel tests; DAT neg AIHA; and more. Provides in-depth clinical reviews on new developments in the understanding and treatment of autoimmune hemolytic anemia, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
metastasis has been made due to costs associated with treatment and hospitalization.4 Advances in early cancer detection and improvements in therapeutic care to patients with systemic cancers are expected to result in reduced metastases ...
SANDRA DEMARINIS, MS, MT(ASCP) Coagulation and Transfusion Medicine, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA VERONICA H. FLOOD, MD Professor, Department of Pediatrics, ...
This issue of Hematology/Oncology Clinics, guest edited by Dr. Glenn J. Hanna, will focus on Head and Neck Cancer. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz.
BRCA1 and BRCA2 mutations increase the risk of breast and ovarian cancer, fallopian tube cancer, male breast cancer, and prostate cancer. Furthermore, BRCA2 mutations are associated with PDAC and melanoma risk, whereas those ...
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sung-Yun Pai and Nirali N. Shah bring their considerable expertise to the topic of Gene-Based Therapies for Pediatric Blood Diseases.
Finally, it is recommended that men with Lynch syndrome consider beginning shared decisionmaking about prostate cancer screening with their physician at age 40 and consider screening at annual intervals rather than every other year.
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Robert Brodsky, is devoted to Complement-mediated Hemolytic Anemias.
Blood. 2010 Sep 16;116(11):1831-8. Epub 2010 Jun 14. Rosse WF, Hillmen P, Schreiber AD. Immune-Mediated Hemolytic Anemia. American Society of Hematology Education Book. 2004. Rund D, Rachmilewitz E. β-thalassemia. N Engl J Med.
This book highlights progress and trends in the rapidly evolving field of complement-related drug discovery and spotlights examples of clinical applications.
Comprehensive and up-to-date clinical reference, with an emphasis on treatment.